Navigation Links
Prostate Oncology Specialists Among First in the Nation to Treat Advanced Prostate Cancer Patients With PROVENGE
Date:10/27/2010

immune system to identify and target prostate cancer cells. Each dose is manufactured specifically for each patient using his immune cells.

The Centers for Medicare and Medicaid Services are currently undergoing a National Coverage Analysis (NCA) regarding autologous cellular immunotherapy treatment of metastatic prostate cancer.  As part of the NCA process, Dr. Scholz will provide an expert opinion on PROVENGE data at the November 17th Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) meeting in Baltimore, MD.

In addition, Dr. Scholz will be giving a presentation on the latest developments in treating advanced prostate cancer, including new immunological approaches such as PROVENGE and effective chemotherapy combinations, at an UsTOO educational session in Fullerton, CA on Thursday, October 28th beginning at 5 p.m. PT.  For press attendance credentials or information on location for patients, please contact Lew Pfeffer at (626) 333-6034.

PROVENGE Safety

PROVENGE is intended solely for autologous use and is not routinely tested for transmissible infectious diseases.

In controlled clinical trials, serious adverse events reported in the PROVENGE group included acute infusion reactions (occurring within 1 day of infusion) and cerebrovascular events.  Severe (Grade 3) acute infusion reactions were reported in 3.5% of patients in the PROVENGE group.  Reactions included chills, fever, fatigue, asthenia, dyspnea, hypoxia, bronchospasm, dizziness, headache, hypertension, muscle ache, nausea, and vomiting. No Grade 4 or 5 acute infusion reactions were reported in patients in the PROVENGE group.

The most common adverse events (incidence >15%) reported in the PROVENGE group are chills, fatigue, fever, back pain, nausea, joint ache, and headache.

Please see full Prescribing Information for PROVENGE at www.provenge.com.

<
'/>"/>

SOURCE Prostate Oncology Specialists, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Reportlinker Adds Prostate Cancer Drug Futures
2. Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Treatment Drug Abiraterone
3. Abiraterone Acetate Significantly Improved Overall Survival for Patients with Metastatic Advanced Prostate Cancer
4. Prostate Cancer Treatment Expert Dr. David Samadi, MD Discusses Study Which Found That Low-Income Men Had High-Risk Prostate Cancer Tumors
5. Phase III Data Showing Improved Survival With Jevtana® (cabazitaxel) Injection in Second-Line Advanced Prostate Cancer Published in The Lancet
6. Surveyed European Oncologists Assign Greater Patient Share to Johnson & Johnsons Abiraterone Compared With Other Emerging Therapies in Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
7. AMS Announces Worldwide Launch of the Revolutionary MoXy™ Liquid Cooled Fiber for Fast, Safe Treatment of Enlarged Prostate
8. With Over 3,000 Robotic Prostatectomy Surgeries to His Credit, Dr. David Samadi, MD Discusses SMART Surgery and How it Improves Sexual and Urinary Function
9. Pfizer Discontinues Phase 3 Trial of SUTENT® in Advanced Castration-Resistant Prostate Cancer
10. Robotic Prostatectomy Expert Dr. David Samadi, MD Introduces His SMART Surgery Website for Prostate Cancer Treatment Education
11. ProstateHealthIndex.org Website Offers Latest on Assessing Prostate Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Sigma-Aldrich Corporation (NASDAQ: ... High Technology company, today announced the opening of ... and state-of-the-art Cell Culture Technical Center in Singapore.  ... provide customized support to meet customer needs, leveraging ... "Our new Technical Center will significantly enhance our ...
(Date:4/17/2015)... TWi Pharmaceuticals, Inc. ("TWi", Stock Ticker:4180.TT) today announced that ... , has obtained state sales licenses from all 50 ... close contact with the major nationwide retail pharmacy distributors ... specialty generic products sold through these nationwide pharmacy distribution ... According to IMS Health, the U.S. pharma market is ...
(Date:4/16/2015)... 2015 Mindray Medical International Limited (NYSE: ... of medical devices worldwide, announced today that it ... Annual Report on Form 20-F that included audited ... An electronic version of Mindray,s Annual Report on ... website at  http://ir.mindray.com  or  http://www.sec.gov . ...
Breaking Medicine Technology:Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 2Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 3Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 4Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 5Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2
... leading provider of medical supplies for care at home, is ... story contest winners. Congratulations to the grand prize winners: LaNedra ... G. of Olympia, WA, and the 5 runners-up, Vivian B. ... of Ypsilanti, MI, Tiffany H. of Monroe, WA and Jorge ...
... of Kensey Nash Corporation (Nasdaq: KNSY ) announced ... $0.25 per share of the Company,s common stock, ... dividend will be paid on February 29, 2012.  This declaration ... board of directors expects to declare a total annual dividend ...
Cached Medicine Technology:Shield HealthCare Announces Caregiver Story Contest Winners 2Kensey Nash Corporation Adopts Cash Dividend Policy; Declares Initial Quarterly Dividend of $0.25 per Share 2Kensey Nash Corporation Adopts Cash Dividend Policy; Declares Initial Quarterly Dividend of $0.25 per Share 3Kensey Nash Corporation Adopts Cash Dividend Policy; Declares Initial Quarterly Dividend of $0.25 per Share 4
(Date:4/17/2015)... York (PRWEB) April 17, 2015 ... allege this class of prescription medications increases the ... attack, stroke or other life-threatening cardiovascular event continue ... U.S. District Court, Northern District of Illinois. According ... U.S. Judicial Panel on Multidistrict Litigation (JPML) on ...
(Date:4/17/2015)... San Francisco, CA (PRWEB) April 17, 2015 The ... Open House event and Free Application Day on April 29. The ... the ACTCM Pioneer Square, located at 555 DeHaro St. in San ... , 11 a.m. – Check in at the DeHaro campus (room ... a.m. – Tour of campus, Noon – Light lunch with current ...
(Date:4/17/2015)... April 17, 2015 With Dr. Taj ... has spent the last four years providing residents ... procedures ranging from general cleanings to dental implants and ... opening at their new office in North Charlotte. , ... as their Concord office, including denture fittings, cosmetic procedures, ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 ... to polish and perfect facial skin with its ... seeds and blend of energizing botanicals. This cushiony ... cells that cause breakouts and inhibit penetration of ... , Ecuadorian Ivory Palm Seeds, This uncommon exfoliating ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Verndale, a ... it has once again been chosen as a Boston ... growing private company in the region. The BBJ’s Pacesetters ... growth from 2011 through 2014. This is the eighth ... ten years that Verndale has been honored with this ...
Breaking Medicine News(10 mins):Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 3Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 4Health News:American College of Traditional Chinese Medicine Hosts Open House 2Health News:Mario Badescu Skin Care Launches Botanical Exfoliating Scrub 2Health News:Verndale Honored as 2015 Boston Business Journal Pacesetter, Named 46th Fastest Growing Private Company 2
... Va. Research reported in the October issue of ... a molecular imaging technique may prove useful in early ... "One of the most promising aspects of molecular ... long before changes in the tumor size and shape ...
... review article published in the October issue of ... Clinic physicians differentiate the ethical and legal permissibility ... comfort measures, specifically palliative sedation, from that of ... that palliative sedation has an important place on ...
... published study in the October 2010 issue of The ... conducted at New York University,s College of Dentistry, confirms ... for controlling xerostomia, or dry mouth. The double masked, ... unique mucoadhesive patch, affixed to the hard palate inside ...
... It Real," an evidence-based sex education curriculum developed by researchers ... (UTHealth), will be implemented in select public schools across the ... tackle the U.S. teenage pregnancy rate. The U.S. ... of its $155-million total package to a team led by ...
... sciences for the developing world, will hold its 21st General ... 350 scientists from 35 countries are expected to attend. Dr. ... delegates at the opening ceremony. The opening ceremony will ... Ernesto Illy Trieste Science Prize and the official presentation of ...
... is a major cause of vision problems in children and ... 70 in developed countries. In amblyopia the person,s stronger eye ... as a result. When the condition is detected and treated ... 20/30 vision or better, the Amblyopia Treatment Study reports. But ...
Cached Medicine News:Health News:Evaluation of targeted therapy in ovarian cancer 2Health News:New approach for treating dry mouth presented in study published in October 2010 issue of JADA 2Health News:New approach for treating dry mouth presented in study published in October 2010 issue of JADA 3Health News:UTHealth researchers awarded $15 million for teen pregnancy prevention 2Health News:TWAS to meet in India 2Health News:Is photoscreening the best way to catch 'lazy eye'? 2
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 6.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 13.0 mm and length 12 mm....
Medicine Products: